ALI HEALTH(00241.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at CNY 1.94 billion, YoY increase of 35.17%

NewTimeSpace News: May 14, 2026, ALI HEALTH(00241.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at CNY 34.26 billion, increased by 11.95% YoY; Net Profit stood at CNY 1.94 billion, YoY increase of 35.22%; Profit Attributable to Shareholders stood at CNY 1.94 billion, YoY increase of 35.17%; Basic Earnings Per Share (EPS) stood at CNY 0.12.

In terms of profitability, ALI HEALTH Gross Profit changed from CNY 7.43 billion in the same period last year to CNY 8.21 billion in the current period, increased by CNY 778.03 million; gross profit margin changed from 24.29% in the same period last year to 23.97% in the current period, decreased by 0.32 percentage points; net profit changed from CNY 1.43 billion in the same period last year to CNY 1.94 billion in the current period, increased by CNY 504.33 million; net profit margin changed from 4.68% in the same period last year to 5.65% in the current period, increased by 0.97 percentage points.

In terms of earnings quality, ALI HEALTH Operating Profit changed from CNY 1.63 billion in the same period last year to CNY 2.27 billion in the current period, increased by CNY 646.22 million; Operating Profit Margin changed from 5.32% in the same period last year to 6.64% in the current period, increased by 1.32 percentage points.

In terms of financial soundness, ALI HEALTH Debt-to-Asset Ratio changed from 22.97% in the same period last year to 22.68% in the current period, decreased by 0.3 percentage points; Total Equity changed from CNY 16.313 billion in the same period last year to CNY 17.857 billion in the current period, increased by CNY 1.54 billion; Current Liabilities changed from CNY 4.74 billion in the same period last year to CNY 5.09 billion in the current period, increased by CNY 351.11 million; Quick Ratio changed from 2.29 in the same period last year to 2.66 in the current period, increased by 0.37 percentage points.

In terms of R&D investment focus, ALI HEALTH R&D Expenses changed from CNY 720.05 million in the same period last year to CNY 788.35 million in the current period, increased by CNY 68.29 million; R&D to Total Revenue Ratio changed from 2.35% in the same period last year to 2.3% in the current period, decreased by 0.05 percentage points.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.